Insider Shareholders with Direct Ownership of Bluebird Bio, Inc. (BLUE)
This section provides a comprehensive overview of the insiders with direct ownership of Bluebird Bio, Inc. (BLUE). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
bluebird bio, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Jason Cole
Chief Strategy & Financial Off |
273,873 | 29,943 | 189,546 $942,043 | 18 |
Aug 19, 2022
Reduced 6.97%
|
|
Gina Consylman
Chief Financial Officer |
125,385 | 0 | 125,385 $623,163 | 2 |
Feb 01, 2022
Added 16.62%
|
|
Jessica Whitten
Chief Accounting Officer |
59,407 | 3,393 | 56,913 $282,857 | 6 |
Feb 01, 2022
Added 11.64%
|
|
David Davidson
Chief Medical Officer |
12,271 | 4,251 | 47,787 $237,501 | 10 |
Apr 05, 2021
Reduced 0.09%
|
|
Christopher Krawtschuk
Chief Financial Officer |
50,000 | 4,526 | 45,474 $226,005 | 2 |
Dec 06, 2023
Reduced 9.05%
|
|
Anne Virginie Eggimann
Chief Regulatory Officer |
17,000 | 1,358 | 42,252 $209,992 | 2 |
Jul 12, 2022
Reduced 3.11%
|
|
Philip D Gregory
Chief Scientific Officer |
95,314 | 3,817 | 34,127 $169,611 | 13 |
Nov 11, 2021
Added %
|
|
Alison Cecily Finger
Chief Commercial Officer |
0 | 1,961 | 25,103 $124,761 | 5 |
Jan 06, 2021
Reduced 2.93%
|
|
William D Baird Iii
Chief Financial Officer |
96,578 | 2,858 | 22,797 $113,301 | 6 |
Nov 11, 2021
Added %
|
|
Joanne Smith Farrell
COO, Oncology |
0 | 1,442 | 20,609 $102,426 | 5 |
Jan 06, 2021
Reduced 2.54%
|
|
Wendy L Dixon
Director |
9,350 | 0 | 11,894 $59,113 | 2 |
Nov 11, 2021
Added 34.41%
|
|
Daniel Lynch
Director |
4,353 | 0 | 7,959 $39,556 | 2 |
Nov 11, 2021
Added %
|
|
Katy Burnett
Principal Accounting Officer |
3,427 | 641 | 4,097 $20,362 | 3 |
Feb 17, 2021
Reduced 11.22%
|
|
William R. Sellers
Director |
3,766 | 0 | 3,601 $17,896 | 2 |
Nov 11, 2021
Added %
|
|
Denice Torres
Director |
4,585 | 0 | 2,726 $13,548 | 2 |
Nov 11, 2021
Added %
|
| 29,563 | 1,478 | 0 $0 | 4 |
Jun 02, 2025
Reduced 100.0%
|
|
| 406,449 | 41,080 | 0 $0 | 21 |
Jun 02, 2025
Reduced 100.0%
|
|
|
Andrew Obenshain
President and CEO |
593,619 | 136,526 | 0 $0 | 33 |
Jun 02, 2025
Reduced 100.0%
|
| 218,692 | 34,192 | 0 $0 | 19 |
Jun 02, 2025
Reduced 100.0%
|
|
| 48,149 | 2,568 | 0 $0 | 7 |
Jun 02, 2025
Reduced 100.0%
|
|
| 37,350 | 1,867 | 0 $0 | 2 |
Jun 02, 2025
Reduced 100.0%
|
|
|
Sarah Js Glickman
Director |
4,663 | 0 | 0 $0 | 2 |
Nov 11, 2021
Added %
|
|
Joseph Vittiglio
Chief Business & Legal Officer |
102,500 | 12,223 | 0 $0 | 7 |
Jun 02, 2025
Reduced 100.0%
|
|
Ramy Ibrahim
Director |
5,359 | 0 | 0 $0 | 3 |
Nov 11, 2021
Added %
|
| 49,393 | 2,497 | 0 $0 | 7 |
Jun 02, 2025
Reduced 100.0%
|
|
|
Marcela V. Maus
Director |
4,663 | 0 | 0 $0 | 2 |
Nov 11, 2021
Added %
|
| 52,823 | 2,408 | 0 $0 | 7 |
Jun 02, 2025
Reduced 100.0%
|
|
| 52,823 | 3,361 | 0 $0 | 8 |
Jun 02, 2025
Reduced 100.0%
|
|
| 43,462 | 2,173 | 0 $0 | 6 |
Jun 02, 2025
Reduced 100.0%
|
|
|
Richard A Colvin
Chief Medical Officer |
137,500 | 25,347 | 0 $0 | 16 |
Jun 02, 2025
Reduced 100.0%
|
|
O. James Sterling
Chief Financial Officer |
102,500 | 7,500 | 0 $0 | 3 |
Jun 02, 2025
Reduced 100.0%
|